Antibody-Drug Conjugates in Bladder Cancer

Urothelial carcinoma (UC) is characterized by expression of a plethora of cell surface antigens, thus offering opportunities for specific therapeutic targeting with use of antibody-drug conjugates (ADCs). ADCs are structured from two major constituents, a monoclonal antibody (mAb) against a specific...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Bladder Cancer
Autori principali: Vlachostergios, Panagiotis J., Jakubowski, Christopher D., Niaz, Muhammad J., Lee, Aileen, Thomas, Charlene, Hackett, Amy L., Patel, Priyanka, Rashid, Naureen, Tagawa, Scott T.
Natura: Artigo
Lingua:Inglês
Pubblicazione: IOS Press 2018
Soggetti:
Review
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6087439/
https://ncbi.nlm.nih.gov/pubmed/30112436
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3233/BLC-180169
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi